AI assistant
Sending…
MASIMO CORP — Director's Dealing 2020
Dec 30, 2020
30755_dirs_2020-12-30_ee1902bb-05e2-46ab-8794-d6f941c7445b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MASIMO CORP (MASI)
CIK: 0000937556
Period of Report: 2020-12-28
Reporting Person: Coleman Jon (Pres-WW OEM & Global Health)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-28 | Common Stock | M | 8250 | $31.01 | Acquired | 20715 | Direct |
| 2020-12-28 | Common Stock | S | 8250 | $264.02 | Disposed | 12465 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-12-28 | Non-Qualified Stock Option (Right to Buy) | $31.01 | M | 8250 | Disposed | 2025-03-20 | Common Stock (8250.0) | Direct |
Footnotes
F1: The shares covered by this Form 4 were sold pursuant to a Rule 10b5-1 Sales Plan dated as of November 25, 2020, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
F2: This option was granted on March 20, 2015 and is exercisable as the option vests. The option vested over a 5 year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
More from MASIMO CORP
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 4
Annual Report
2026
May 1
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 26
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 17